Growth Metrics

Astrana Health (ASTH) Return on Equity (2016 - 2025)

Astrana Health (ASTH) has disclosed Return on Equity for 15 consecutive years, with 0.03% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 4.0% to 0.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03% through Dec 2025, down 4.0% year-over-year, with the annual reading at 0.03% for FY2025, 4.0% down from the prior year.
  • Return on Equity hit 0.03% in Q4 2025 for Astrana Health, up from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.39% in Q1 2021 to a low of 0.0% in Q2 2022.
  • Historically, Return on Equity has averaged 0.1% across 5 years, with a median of 0.08% in 2024.
  • Biggest YoY gain for Return on Equity was 27bps in 2021; the steepest drop was -33bps in 2021.
  • Year by year, Return on Equity stood at 0.1% in 2021, then decreased by -16bps to 0.09% in 2022, then dropped by -14bps to 0.07% in 2023, then decreased by -6bps to 0.07% in 2024, then tumbled by -56bps to 0.03% in 2025.
  • Business Quant data shows Return on Equity for ASTH at 0.03% in Q4 2025, 0.01% in Q3 2025, and 0.04% in Q2 2025.